Ngā hua rapu - Kyong‐Mi Chang

Whakamahine hua
  1. 1
    Hepatitis C virus: virology and life cycle

    Hepatitis C virus: virology and life cycle mā Chang Wook Kim, Kyong–Mi Chang

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure

    Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure mā David Yardeni, Kyong–Mi Chang, Marc G. Ghany

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Prospects for the Global Elimination of Hepatitis B

    Prospects for the Global Elimination of Hepatitis B mā Timothy M. Block, Kyong‐Mi Chang, Ju‐Tao Guo

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Hepatitis C Virus Transmission Bottlenecks Analyzed by Deep Sequencing

    Hepatitis C Virus Transmission Bottlenecks Analyzed by Deep Sequencing mā Gary P. Wang, Scott Sherrill-Mix, Kyong–Mi Chang, Christopher Quince, Frederic D. Bushman

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Deep immune profiling by mass cytometry links human T and NK cell differentiation and cytotoxic molecule expression patterns

    Deep immune profiling by mass cytometry links human T and NK cell differentiation and cytotoxic molecule expression patterns mā Bertram Bengsch, Takuya Ohtani, Ramin S. Herati, Niels Bovenschen, Kyong–Mi Chang, E. John Wherry

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

    Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection mā Robert Thimme, David Oldach, Kyong–Mi Chang, Carola Steiger, Stuart C. Ray, Francis V. Chisari

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Different affinity windows for virus and cancer‐specific <scp>T</scp>‐cell receptors: Implications for therapeutic strategies

    Different affinity windows for virus and cancer‐specific <scp>T</scp>‐cell receptors: Implications for therapeutic strategies mā Milos Aleksic, Nathaniel Liddy, Peter Molloy, Nick Pumphrey, Annelise Vuidepot, Kyong–Mi Chang, Bent K. Jakobsen

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.

    Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. mā Barbara Rehermann, Kyong–Mi Chang, John G. McHutchison, Robert Kokka, Michael Houghton, Francis V. Chisari

    I whakaputaina 1996
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    AASLD guidelines for treatment of chronic hepatitis B

    AASLD guidelines for treatment of chronic hepatitis B mā Norah A. Terrault, Natalie Bzowej, Kyong–Mi Chang, Jessica Hwang, Maureen M. Jonas, M. Hassan Murad

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response

    Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response mā Kazushi Sugimoto, Jason Stadanlick, Fusao Ikeda, Colleen Brensinger, Emma E. Furth, Harvey J. Alter, Kyong‐Mi Chang

    I whakaputaina 2003
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.

    Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. mā Kyong–Mi Chang, Barbara Rehermann, John G. McHutchison, C Pasquinelli, Scott Southwood, Alessandro Sette, Francis V. Chisari

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

    Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients mā Barbara Rehermann, Kyong–Mi Chang, John McHutchinson, Robert Kokka, Michael Houghton, Charles M. Rice, Francis V. Chisari

    I whakaputaina 1996
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Identification of HLA-A3 and -B7-Restricted CTL Response to Hepatitis C Virus in Patients with Acute and Chronic Hepatitis C

    Identification of HLA-A3 and -B7-Restricted CTL Response to Hepatitis C Virus in Patients with Acute and Chronic Hepatitis C mā Kyong‐Mi Chang, Norbert H. Gruener, Scott Southwood, John Sidney, Gerd R. Pape, Francis V. Chisari, Alessandro Sette

    I whakaputaina 1999
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-Positive B-cell population

    Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-Positive B-cell population mā Hiroyoshi Doi, Tara K. Iyer, Erica L. Carpenter, Hong Li, Kyong–Mi Chang, Robert H. Vonderheide, David E. Kaplan

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad

    Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad mā Marc G. Ghany, Jordan J. Feld, Kyong–Mi Chang, Henry Lik‐Yuen Chan, Anna S. Lok, Kumar Visvanathan, Harry L.A. Janssen

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis

    Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis mā David E. Kaplan, Fusao Ikeda, Yun Li, Nobuhiro Nakamoto, Sutharsan Ganesan, Mary E. Valiga, Frederick A. Nunes, K. Rajender Reddy, Kyong–Mi Chang

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Identification and In Vitro Expansion of Functional Antigen-Specific CD25 <sup>+</sup> FoxP3 <sup>+</sup> Regulatory T Cells in Hepatitis C Virus Infection

    Identification and In Vitro Expansion of Functional Antigen-Specific CD25 <sup>+</sup> FoxP3 <sup>+</sup> Regulatory T Cells in Hepatitis C Virus Infection mā Hirotoshi Ebinuma, Nobuhiro Nakamoto, Yun Li, David A. Price, Emma Gostick, Bruce L. Levine, John W. Tobias, William W. Kwok, Kyong–Mi Chang

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain

    Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain mā Jens Bukh, Robert Thimme, Jean‐Christophe Meunier, Kristina Faulk, Hans Christian Spangenberg, Kyong–Mi Chang, William C. Satterfield, Francis V. Chisari, Robert H. Purcell

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

    Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance mā Norah A. Terrault, Anna S. Lok, Brian J. McMahon, Kyong–Mi Chang, Jessica Hwang, Maureen M. Jonas, Robert S. Brown, Natalie Bzowej, John B. Wong

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance

    Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance mā Norah A. Terrault, Anna S. Lok, Brian J. McMahon, Kyong–Mi Chang, Jessica Hwang, Maureen M. Jonas, Robert S. Brown, Natalie Bzowej, John B. Wong

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: